Title: Real-world characteristics of “super-responders” to mepolizumab and benralizumab in severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis.
Citation: ERJ Open Res
2023;9:00419–2023.
Country: Italy |
Indication: Asthma
|
Comorbidity: EGPA
Scan to access the publication or visit
http://tago.ca/37908397
http://tago.ca/37908397